Brain natriuretic peptide is a long-term cardiovascular predictor in carotid endarterectomy

References

• Orrapin S, Rerkasem K. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev. 2017;6(6):Cd001081. doi:10.1002/14651858.CD001081.pub4.
   PubMedGoogle Scholar
• Gasior SA, O’Donnell JPM, Davey M, et al. Optimal management of asymptomatic carotid artery stenosis: a systematic review and network meta-analysis. Eur J Vasc Endovasc Surg. 2023;65(5):690–699. doi:10.1016/j.ejvs.2023.01.020.
   PubMed Web of Science ®Google Scholar
• Müller MD, Lyrer P, Brown MM, et al. Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis. Cochrane Database Syst Rev. 2020;2(2):Cd000515. doi:10.1002/14651858.CD000515.pub5.
   PubMedGoogle Scholar
• Chen X, Su J, Wang G, et al. Safety and efficacy of early carotid endarterectomy in patients with symptomatic carotid artery stenosis: a meta-analysis. Biomed Res Int. 2021;2021:6623426. doi:10.1155/2021/6623426.
   PubMed Web of Science ®Google Scholar
• Naylor, Ross, Rantner, Barbara, Ancetti, Stefano, et al. Editor’s Choice - European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease. Eur J Vasc Endovasc Surg. 2023;65(1):7–111. doi:10.1016/j.ejvs.2022.04.011.
   PubMed Web of Science ®Google Scholar
• Lokuge K, de Waard DD, Halliday A, et al. Meta-analysis of the procedural risks of carotid endarterectomy and carotid artery stenting over time. Br J Surg. 2018;105(1):26–36. doi:10.1002/bjs.10717.
   PubMed Web of Science ®Google Scholar
• Halvorsen S, Mehilli J, Cassese S, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC). Eur Heart J. 2022;43(39):3826–3924. doi:10.1093/eurheartj/ehac270.
   PubMed Web of Science ®Google Scholar
• Li N, Wang JA. Brain natriuretic peptide and optimal management of heart failure. J Zhejiang Univ Sci B. 2005;6(9):877–884. doi:10.1631/jzus.2005.B0877.
   PubMedGoogle Scholar
• Duceppe E, Parlow J, MacDonald P, et al. Canadian cardiovascular society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Can J Cardiol. 2017;33(1):17–32. doi:10.1016/j.cjca.2016.09.008.
   PubMed Web of Science ®Google Scholar
• Biccard BM, Naidoo P. The role of brain natriuretic peptide in prognostication and reclassification of risk in patients undergoing vascular surgery*. Anaesthesia. 2011;66(5):379–385. doi:10.1111/j.1365-2044.2011.06694.x.
   PubMed Web of Science ®Google Scholar
• Rodseth RN, Biccard BM, Le Manach Y, et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J Am Coll Cardiol. 2014;63(2):170–180. doi:10.1016/j.jacc.2013.08.1630.
   PubMed Web of Science ®Google Scholar
• Huang B, Yang GK, Strandberg S, et al. Exploring the utility of brain natriuretic peptide measurement in vascular surgery. Ann Vasc Surg. 2022;78:233–238. doi:10.1016/j.avsg.2021.05.066.
   PubMed Web of Science ®Google Scholar
• Khan A, Johnson DK, Carlson S, et al. NT-Pro BNP predicts myocardial injury post-vascular surgery and is reduced with CoQ10: A randomized double-blind trial. Ann Vasc Surg. 2020;64:292–302.
   Google Scholar
• Schouten O, Hoeks SE, Goei D, et al. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery. J Vasc Surg. 2009;49(2):435–442. doi:10.1016/j.jvs.2008.08.063.
   PubMed Web of Science ®Google Scholar
• Agha R, Borrelli M, Vella-Baldacchino M, Group S., et al. The STROCSS statement: strengthening the Reporting of Cohort Studies in Surgery. Int J Surg. 2017;46:198–202. doi:10.1016/j.ijsu.2017.08.586.
   PubMed Web of Science ®Google Scholar
• Oates CP, Naylor AR, Hartshorne T, et al. Joint recommendations for reporting carotid ultrasound investigations in the United Kingdom. Eur J Vasc Endovasc Surg. 2009;37(3):251–261. doi:10.1016/j.ejvs.2008.10.015.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Glob Heart. 2018;13(4):305–338. doi:10.1016/j.gheart.2018.08.004.
   PubMed Web of Science ®Google Scholar
• McDonagh TA, Metra MA-O, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. (1879-0844 (Electronic)).
   Google Scholar
• Brott TG, Hobson RW, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11–23. doi:10.1056/NEJMoa0912321.
   PubMed Web of Science ®Google Scholar
• Ryding Alisdair DS, Kumar S, Worthington Angela M, et al. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis. Anesthesiology. 2009;111(2):311–319. doi:10.1097/ALN.0b013e3181aaeb11.
   PubMed Web of Science ®Google Scholar
• Zhang LJ, Li N, Li Y, et al. Cardiac biomarkers predicting MACE in patients undergoing noncardiac surgery: a meta-analysis. Front Physiol. 2018;9:1923. doi:10.3389/fphys.2018.01923.
   PubMed Web of Science ®Google Scholar
• Hendricks S, Dykun I, Balcer B, et al. Higher BNP/NT-pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta-analysis. ESC Heart Fail. 2022;9(5):3198–3209. doi:10.1002/ehf2.14019.
   PubMed Web of Science ®Google Scholar
• Rodseth RN, Padayachee L, Biccard BM. A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia. 2008;63(11):1226–1233. doi:10.1111/j.1365-2044.2008.05574.x.
   PubMed Web of Science ®Google Scholar
• Stone PA, Thompson SN, Khan M, et al. The impact of biochemical markers on major adverse cardiovascular events and contralateral carotid artery stenosis progression following carotid interventions. Ann Vasc Surg. 2017;38:144–150
   Google Scholar
• Rodseth RN, Lurati Buse GA, Bolliger D, et al. The predictive ability of pre-operative B-type natriuretic peptide in vascular patients for major adverse cardiac events: an individual patient data meta-analysis. J Am Coll Cardiol. 2011;58(5):522–529. doi:10.1016/j.jacc.2011.04.018.
   PubMed Web of Science ®Google Scholar
• Qu C, Liao S, Zhang J, et al. Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019. Eur Heart J Qual Care Clin Outcomes. 2024;10(2):143–153. doi:10.1093/ehjqcco/qcad033.
   PubMed Web of Science ®Google Scholar
• Ishigaki T, Yoshida T, Izumi H, et al. Different implication of elevated B-type natriuretic peptide level in patients with heart failure with preserved ejection fraction and in those with reduced ejection fraction. Echocardiography. 2015;32(4):623–629. doi:10.1111/echo.12707.
   PubMed Web of Science ®Google Scholar
• Niizuma S, Iwanaga Y, Yahata T, et al. Plasma B-type natriuretic peptide levels reflect the presence and severity of stable coronary artery disease in chronic haemodialysis patients. Nephrol Dial Transplant. 2009;24(2):597–603. doi:10.1093/ndt/gfn491.
   PubMed Web of Science ®Google Scholar
• Malakar AK, Choudhury D, Halder B, et al. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019;234(10):16812–16823. doi:10.1002/jcp.28350.
   PubMed Web of Science ®Google Scholar
• Triposkiadis F, Xanthopoulos A, Parissis J, et al. Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers. Heart Fail Rev. 2022;27(1):337–344. doi:10.1007/s10741-020-09987-z.
   PubMed Web of Science ®Google Scholar
• Staerk L, Sherer JA, Ko D, et al. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;120(9):1501–1517. doi:10.1161/CIRCRESAHA.117.309732.
   PubMed Web of Science ®Google Scholar
• Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006;92(6):843–849. doi:10.1136/hrt.2005.071233.
   PubMed Web of Science ®Google Scholar
• Galasko GIW, Lahiri A, Barnes SC, et al. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? Eur Heart J. 2005;26(21):2269–2276. doi:10.1093/eurheartj/ehi410.
   PubMed Web of Science ®Google Scholar
• Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40(5):976–982. doi:10.1016/s0735-1097(02)02059-4.
   PubMed Web of Science ®Google Scholar
• Keyzer JM, Hoffmann JJ, Ringoir L, et al. Age- and gender-specific brain natriuretic peptide (BNP) reference ranges in primary care. Clin Chem Lab Med. 2014;52(9):1341–1346.). doi:10.1515/cclm-2013-0791.
   PubMed Web of Science ®Google Scholar
• Kerr B, Brandon L. Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP - A narrative review. Int J Cardiol Heart Vasc. 2022;43:101132. doi:10.1016/j.ijcha.2022.101132.
   PubMed Web of Science ®Google Scholar